Germany· DE-A57-15ea22b3be3e5f3a

Jodid

A potassium iodide product containing potassium iodide, registered in Germany by Viatris Germany Gmbh. The same ATC class is registered in 4 of our 19 countries.

ATC R05CA02

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedJodidATCR05CA02REGISTER NO.DE-A57-15ea22b3be3e5f…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Potassium iodide is registered in 4 of 19 countries.

Countries holding a registration under ATC R05CA02 (potassium iodide), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 1 of them publish a price we can compare per daily dose

Potassium iodide · ATC R05CA02

4 / 19 countries

  • Germany
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Potassium Iodide
Manufacturer
Viatris Germany Gmbh
Country
Germany (DE)
ATC code
R05CA02
ATC class
Potassium iodide
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

45 interactions on record for potassium iodide.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Potassium iodide · interactions on record

45 records

  • 19 severe
  • 26 moderate

Most severe, free to view

  • EplerenoneC03DA04severe
  • CaptoprilC09AA01severe
  • EnalaprilC09AA02severe
  • LisinoprilC09AA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6a14f26-883c-4243-b180-222c75caf05a
GET /v1/drugs/c6a14f26-883c-4243-b180-222c75caf05a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Potassium Iodide",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about potassium iodide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.